Literature DB >> 23983394

Ethanolic extract of Aconiti Brachypodi Radix attenuates nociceptive pain probably via inhibition of voltage-dependent Na⁺ channel.

Wei Ren1, Lin Yuan, Jun Li, Xian-Ju Huang, Su Chen, Da-Jiang Zou, Xiangming Liu, Xin-Zhou Yang.   

Abstract

Aconiti Brachypodi Radix, belonging to the genus of Aconitum (Family Ranunculaceae), are used clinically as anti-rheumatic, anti-inflammatory and anti-nociceptive in traditional medicine of China. However, its mechanism and influence on nociceptive threshold are unknown and need further investigation. The analgesic effects of ethanolic extract of Aconiti Brachypodi Radix (EABR) were thus studied in vivo and in vitro. Three pain models in mice were used to assess the effect of EABR on nociceptive threshold. In vitro study was conducted to clarify the modulation of the extract on the tetrodotoxin-sensitive (TTX-S) sodium currents in rat's dorsal root ganglion (DRG) neurons using whole-cell patch clamp technique. The results showed that EABR (5-20 mg/kg, i.g.) could produce dose-dependent analgesic effect on hot-plate tests as well as writhing response induced by acetic acid. In addition, administration of 2.5-10 mg/kg EABR (i.g.) caused significant decrease in pain responses in the first and second phases of formalin test without altering the PGE₂ production in the hind paw of the mice. Moreover, EABR (10 µg/ml -1 mg/ml) could suppress TTX-S voltage-gated sodium currents in a dose-dependent way, indicating the underlying electrophysiological mechanism of the analgesic effect of the folk plant medicine. Collectively, our results indicated that EABR has analgesic property in three pain models and useful influence on TTX-S sodium currents in DRG neurons, suggesting that the interference with pain messages caused by the modulation of EABR on TTX-S sodium currents in DRG neurones may explain some of its analgesic effect.

Entities:  

Keywords:  Aconiti Brachypodi Radix; analgesic effect; dorsal root ganglion; sodium channel

Mesh:

Substances:

Year:  2012        PMID: 23983394      PMCID: PMC3746645          DOI: 10.4314/ajtcam.v9i4.15

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  24 in total

1.  Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons.

Authors:  S Tate; S Benn; C Hick; D Trezise; V John; R J Mannion; M Costigan; C Plumpton; D Grose; Z Gladwell; G Kendall; K Dale; C Bountra; C J Woolf
Journal:  Nat Neurosci       Date:  1998-12       Impact factor: 24.884

Review 2.  The formalin test: an evaluation of the method.

Authors:  Arne Tjølsen; Odd-Geir Berge; Steinar Hunskaar; Jan Henrik Rosland; Kjell Hole
Journal:  Pain       Date:  1992-10       Impact factor: 6.961

3.  Neurogenic and tissue-mediated components of formalin-induced edema: evidence for supraspinal regulation.

Authors:  H Wheeler-Aceto; A Cowan
Journal:  Agents Actions       Date:  1991-09

4.  Studies on kochiae fructus. III. Antinociceptive and antiinflammatory effects of 70% ethanol extract and its component, momordin Ic from dried fruits of Kochia scoparia L.

Authors:  H Matsuda; Y Dai; Y Ido; S Ko; M Yoshikawa; M Kubo
Journal:  Biol Pharm Bull       Date:  1997-10       Impact factor: 2.233

5.  A method for evaluating analgesic agents in rats.

Authors:  K Fukawa; O Kawano; M Hibi; N Misaki; S Ohba; Y Hatanaka
Journal:  J Pharmacol Methods       Date:  1980-11

6.  Sodium channel accumulation in humans with painful neuromas.

Authors:  J D England; L T Happel; D G Kline; F Gamboni; C L Thouron; Z P Liu; S R Levinson
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

7.  Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice.

Authors:  A R Santos; J B Calixto
Journal:  Neurosci Lett       Date:  1997-10-10       Impact factor: 3.046

8.  The formalin test in mice: dissociation between inflammatory and non-inflammatory pain.

Authors:  Steinar Hunskaar; Kjell Hole
Journal:  Pain       Date:  1987-07       Impact factor: 6.961

Review 9.  The effects of Aconitum alkaloids on the central nervous system.

Authors:  A Ameri
Journal:  Prog Neurobiol       Date:  1998-10       Impact factor: 11.685

10.  Antiinflammatory principles of Aconitum roots.

Authors:  H Hikino; C Konno; H Takata; Y Yamada; C Yamada; Y Ohizumi; K Sugio; H Fujimura
Journal:  J Pharmacobiodyn       Date:  1980-10
View more
  5 in total

1.  Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation.

Authors:  Yanqiong Zhang; Ming Bai; Bo Zhang; Chunfang Liu; Qiuyan Guo; Yanqun Sun; Danhua Wang; Chao Wang; Yini Jiang; Na Lin; Shao Li
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.379

2.  Anti-allodynic effect of intrathecal processed Aconitum jaluense is associated with the inhibition of microglial activation and P2X7 receptor expression in spinal cord.

Authors:  Jihoon Yang; Keun Suk Park; Jae Joon Yoon; Hong-Beom Bae; Myung Ha Yoon; Jeong Il Choi
Journal:  BMC Complement Altern Med       Date:  2016-07-13       Impact factor: 3.659

3.  Bullatine A exerts anti-inflammatory effects by inhibiting the ROS/JNK/NF-κB pathway and attenuating systemic inflammatory responses in mice.

Authors:  Shuhan Liu; Na Che; Wen Ou; Meichen Yan; Yajin Liao; Yong Cheng
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

4.  Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain models.

Authors:  Qian Huang; Xiao-Fang Mao; Hai-Yun Wu; Teng-Fei Li; Ming-Li Sun; Hao Liu; Yong-Xiang Wang
Journal:  J Neuroinflammation       Date:  2016-08-30       Impact factor: 8.322

5.  Mechanical allodynia triggered by cold exposure in mice with the Scn11a p.R222S mutation: a novel model of drug therapy for neuropathic pain related to NaV1.9.

Authors:  Yosuke Matsubara; Hiroko Okuda; Kouji H Harada; Shohab Youssefian; Akio Koizumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-09-24       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.